Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

The Multi-kinase Inhibitor Debio 0617B Reduces Maintenance and Self-renewal of Primary Human AML CD34+ Stem/Progenitor Cells.

Murone M, Radpour R, Attinger A, Chessex AV, Huguenin AL, Schürch CM, Banz Y, Sengupta S, Aguet M, Rigotti S, Bachhav Y, Massière F, Ramachandra M, McAllister A, Riether C.

Mol Cancer Ther. 2017 Aug;16(8):1497-1510. doi: 10.1158/1535-7163.MCT-16-0889. Epub 2017 May 3.

2.

Debio 0617B Inhibits Growth of STAT3-Driven Solid Tumors through Combined Inhibition of JAK, SRC, and Class III/V Receptor Tyrosine Kinases.

Murone M, Vaslin Chessex A, Attinger A, Ramachandra R, Shetty SJ, Daginakatte G, Sengupta S, Marappan S, Dhodheri S, Rigotti S, Bachhav Y, Brienza S, Traxler P, Lang M, Aguet M, Zoete V, Michielin O, Nicholas C, Johnson FM, Ramachandra M, McAllister A.

Mol Cancer Ther. 2016 Oct;15(10):2334-2343. Epub 2016 Jul 20.

3.

Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology.

Bachhav YG, Heinrich A, Kalia YN.

Eur J Pharm Biopharm. 2013 Jun;84(2):355-64. doi: 10.1016/j.ejpb.2012.11.018. Epub 2012 Nov 30.

PMID:
23207321
4.

Using controlled laser-microporation to increase transdermal delivery of prednisone.

Yu J, Bachhav YG, Summer S, Heinrich A, Bragagna T, Böhler C, Kalia YN.

J Control Release. 2010 Nov 20;148(1):e71-3. doi: 10.1016/j.jconrel.2010.07.032. No abstract available.

PMID:
21529638
5.

Using laser microporation to improve transdermal delivery of diclofenac: Increasing bioavailability and the range of therapeutic applications.

Bachhav YG, Heinrich A, Kalia YN.

Eur J Pharm Biopharm. 2011 Aug;78(3):408-14. doi: 10.1016/j.ejpb.2011.03.006. Epub 2011 Mar 21.

PMID:
21397689
6.

Novel micelle formulations to increase cutaneous bioavailability of azole antifungals.

Bachhav YG, Mondon K, Kalia YN, Gurny R, Möller M.

J Control Release. 2011 Jul 30;153(2):126-32. doi: 10.1016/j.jconrel.2011.03.003. Epub 2011 Mar 22.

PMID:
21397643
7.

Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation.

Bachhav YG, Patravale VB.

Acta Pharm. 2010 Jun;60(2):153-63. doi: 10.2478/v10007-010-0020-0.

PMID:
21134852
8.

Development and validation of a rapid high-performance liquid chromatography method for the quantification of exenatide.

Bachhav YG, Kalia YN.

Biomed Chromatogr. 2011 Jul;25(7):838-42. doi: 10.1002/bmc.1526. Epub 2010 Sep 27.

PMID:
20878660
9.

Effect of controlled laser microporation on drug transport kinetics into and across the skin.

Bachhav YG, Summer S, Heinrich A, Bragagna T, Böhler C, Kalia YN.

J Control Release. 2010 Aug 17;146(1):31-6. doi: 10.1016/j.jconrel.2010.05.025. Epub 2010 May 25.

PMID:
20678988
10.

Development and validation of an analytical method for the quantification of cytochrome c in skin transport studies.

Bachhav YG, Kalia YN.

Biomed Chromatogr. 2010 Jul;24(7):732-6. doi: 10.1002/bmc.1356.

PMID:
19882748
11.

Stability of triptorelin in the presence of dermis and epidermis.

Bachhav YG, Kalia YN.

Int J Pharm. 2009 Aug 13;378(1-2):149-51. doi: 10.1016/j.ijpharm.2009.05.053. Epub 2009 May 30.

PMID:
19486932
12.

Microemulsion-based vaginal gel of clotrimazole: formulation, in vitro evaluation, and stability studies.

Bachhav YG, Patravale VB.

AAPS PharmSciTech. 2009;10(2):476-81. doi: 10.1208/s12249-009-9233-2. Epub 2009 Apr 21.

13.

SMEDDS of glyburide: formulation, in vitro evaluation, and stability studies.

Bachhav YG, Patravale VB.

AAPS PharmSciTech. 2009;10(2):482-7. doi: 10.1208/s12249-009-9234-1. Epub 2009 Apr 21.

14.

Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation.

Bachhav YG, Patravale VB.

Int J Pharm. 2009 Jan 5;365(1-2):175-9. doi: 10.1016/j.ijpharm.2008.08.021. Epub 2008 Aug 23.

PMID:
18790032
15.

Exploring the potential of N-methyl pyrrolidone as a cosurfactant in the microemulsion systems.

Bachhav YG, Date AA, Patravale VB.

Int J Pharm. 2006 Dec 1;326(1-2):186-9. Epub 2006 Jul 15.

PMID:
16949777

Supplemental Content

Loading ...
Support Center